Medicine and Dentistry
Nodular Melanoma
100%
Neoplasm
94%
Non Small Cell Lung Cancer
54%
Metastatic Carcinoma
29%
Malignant Neoplasm
28%
Activated Leukocyte Cell Adhesion Molecule
26%
Diagnosis
25%
Metastatic Melanoma
24%
Epidermal Growth Factor Receptor
23%
Next Generation Sequencing
22%
Squamous Cell Carcinoma
21%
Cutaneous Melanoma
21%
Targeted Therapy
19%
Melanoma Cell
18%
Biopsy
17%
Vulvar Intraepithelial Neoplasia
15%
Immunohistochemistry
14%
Tumor Progression
14%
Disease
13%
Biological Marker
12%
Gene Expression
12%
Cell-Free DNA
12%
Lichen Sclerosus
12%
Overall Survival
11%
Lung Cancer
11%
Cytotechnology
11%
microRNA
10%
Tumor Cell
10%
Lymph Node Metastasis
9%
Collagen Type 1
9%
Formaldehyde
9%
Gelatinase B
9%
Exon
9%
Molecular Pathology
8%
Circulating Tumor DNA
8%
Molecular Diagnosis
8%
Carcinoma
8%
Melanoma Cell Line
8%
Hypoxia
8%
In Vitro
8%
Disease Exacerbation
8%
Protein P53
8%
Cancer Treatment
8%
Angiogenesis
7%
Ovarian Cancer
7%
Lung Adenocarcinoma
7%
Tyrosinase Related Protein 1
7%
Vulva
7%
Pelvic Organ Prolapse
7%
Colorectal Carcinoma
7%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
33%
Next Generation Sequencing
23%
Decision Making
16%
Circulating Tumor DNA
15%
Messenger RNA
14%
KRAS
14%
Gene Expression Profiling
13%
Prevalence
12%
MicroRNA
11%
Tumor Suppressor Gene
11%
Gene Expression
11%
Fibroblast
10%
Transcriptome
10%
Exon
8%
Angiogenesis
8%
Genetics
8%
RNA
8%
Progression Free Survival
7%
Homeostasis
7%
Matrix Protein
7%
ROS1
7%
Single-Nucleotide Polymorphism
7%
Methylation
7%
MMP9
7%
Gelatinase B
7%
Type I Collagen
7%
Gene Amplification
7%
Nucleic Acid Base Substitution
7%
Activated Leukocyte Cell Adhesion Molecule
7%
Synapsin I
7%
Growth Factor
6%
Matrix Metalloproteinase
6%
Tumor Progression
5%
Transcription Factors
5%
Mediator
5%
Cancer Cell
5%
TGF Beta 1
5%
Epithelial Cell Adhesion Molecule
5%
Overall Survival
5%
Keyphrases
Molecular Diagnostics
16%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
15%
Non-small Cell Lung Cancer (NSCLC)
14%
Circulating Tumor DNA (ctDNA)
12%
Pelvic Organ Prolapse
11%
Activated Leukocyte Cell Adhesion Molecule
11%
Predictive Biomarker
11%
Biomarker Testing
11%
Targeted Therapy
10%
Vulvar Squamous Cell Carcinoma
9%
Tumor
9%
COL3A1
7%
Neoplastic Cells
7%
Lichen Sclerosus
7%
MRNA Expression
7%
Tumor Microenvironment
7%
Cancer Patients
7%
Genomic Scars
7%
Advanced Lung Adenocarcinoma
7%
DNA Sequencing
7%
Quantitative PCR
6%
Molecular Tumor Board
6%
Dutch
6%
Differentiated Vulvar Intraepithelial Neoplasia (dVIN)
6%
Metastatic Non-small Cell Lung Cancer
5%
In Cancer
5%
Netherlands
5%
Prognostic Value
5%
Polymorphism
5%
Lymph Node Metastasis
5%
Metastasizing
5%
Metastatic Melanoma
5%
Melanoma
5%
High-risk Melanoma
5%
